Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Wolpow Richard — Pharmagen, Inc. insider: 1 transactions · InsiderLens

/ / Wolpow Richard

Wolpow Richard

Director at Pharmagen, Inc. · on record since Mar 4, 2014
Int. Chief Operating Officer at Pharmagen, Inc. · on record since Mar 4, 2014

Insider trading activity of Wolpow Richard

Transactions on record: 1; since Apr 3, 2014

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 3, 2014

Figures computed from official regulatory filings — .

Companies where Wolpow Richard has traded

Pharmagen, Inc.1 tx · $100K · Apr 3, 2014

Track record of Wolpow Richard

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Wolpow Richard

Co-insiders of Wolpow Richard

BARCH MACKIEPharmagen, Inc.
Barnes DannyPharmagen, Inc.
BETHESDA HOLDINGS LLCPharmagen, Inc.
CLARKE ERICPharmagen, Inc.
OLD LINE PARTNERS LLCPharmagen, Inc.
Perry Stephen M.Pharmagen, Inc.
Relac Boyd P.Pharmagen, Inc.
Rowley DavidPharmagen, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Pharmagen, Inc.Listing on record	Apr 3, 2014	BuyD (derivative)	100,000	1.00 USD	$100K	First in 12mo	SEC